BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marcus SG, Cohen D, Lin K, Wong K, Thompson S, Rothberger A, Potmesil M, Hiotis S, Newman E. Complications of gastrectomy following CPT-11-based neoadjuvant chemotherapy for gastric cancer. J Gastrointest Surg. 2003;7:1015-1022; discussion 1023. [PMID: 14675711 DOI: 10.1016/j.gassur.2003.09.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Galata C, Ronellenfitsch U, Blank S, Reißfelder C, Hardt J. Postoperative Morbidity and Failure to Rescue in Surgery for Gastric Cancer: A Single Center Retrospective Cohort Study of 1107 Patients from 1972 to 2014. Cancers (Basel) 2020;12:E1953. [PMID: 32708438 DOI: 10.3390/cancers12071953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Galata C, Blank S, Weiss C, Ronellenfitsch U, Reissfelder C, Hardt J. Role of Postoperative Complications in Overall Survival after Radical Resection for Gastric Cancer: A Retrospective Single-Center Analysis of 1107 Patients. Cancers (Basel) 2019;11:E1890. [PMID: 31783704 DOI: 10.3390/cancers11121890] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
3 Minarich MJ, Schwarz RE. A Simplified Two-Step Technique for Extended Lymphadenectomy During Resection of Gastroesophageal Malignancy: Early Results Compared to En Bloc Dissection. J Gastrointest Surg 2019;23:393-401. [PMID: 30603860 DOI: 10.1007/s11605-018-4056-7] [Reference Citation Analysis]
4 Wang Y, Zhuang RY, Yu YY, Yu S, Hou J, Ji Y, Sun YH, Shen KT, Shen ZB, Liu FL, Zhao NQ, Liu TS. Efficacy of preoperative chemotherapy regimens in patients with initially unresectable locally advanced gastric adenocarcinoma: capecitabine and oxaliplatin (XELOX) or with epirubicin (EOX). Oncotarget 2016;7:76298-307. [PMID: 27602586 DOI: 10.18632/oncotarget.11818] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
5 Chang KK, Park do J, Yoon SS. Laparoscopic Versus Open Surgery for Gastric Adenocarcinoma: Innovation Continues to Challenge Tradition. Ann Surg 2016;264:223-5. [PMID: 27163952 DOI: 10.1097/SLA.0000000000001786] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
6 Memon MA, Memon B. Laparoscopic D2 distal gastrectomy for advanced gastric cancer: a myth or a reality? Transl Gastroenterol Hepatol 2016;1:39. [PMID: 28138606 DOI: 10.21037/tgh.2016.05.01] [Reference Citation Analysis]
7 Achiam MP, Jensen LB, Larsson H, Jensen LS, Larsen AC, Holm J, Svendsen LB. Comparative Investigation of Postoperative Complications in Patients With Gastroesophageal Junction Cancer Treated With Preoperative Chemotherapy or Surgery Alone. Scand J Surg 2016;105:22-8. [DOI: 10.1177/1457496915577021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Wang Y, Yu YY, Li W, Feng Y, Hou J, Ji Y, Sun YH, Shen KT, Shen ZB, Qin XY, Liu TS. A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis. Cancer Chemother Pharmacol. 2014;73:1155-1161. [PMID: 24748418 DOI: 10.1007/s00280-014-2449-1] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
9 Schmidt B, Chang KK, Maduekwe UN, Look-Hong N, Rattner DW, Lauwers GY, Mullen JT, Yang HK, Yoon SS. D2 lymphadenectomy with surgical ex vivo dissection into node stations for gastric adenocarcinoma can be performed safely in Western patients and ensures optimal staging. Ann Surg Oncol. 2013;20:2991-2999. [PMID: 23760588 DOI: 10.1245/s10434-013-3019-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
10 Schmidt B, Yoon SS. D1 versus D2 lymphadenectomy for gastric cancer. J Surg Oncol. 2013;107:259-264. [PMID: 22513454 DOI: 10.1002/jso.23127] [Cited by in Crossref: 46] [Cited by in F6Publishing: 54] [Article Influence: 4.6] [Reference Citation Analysis]
11 Schmidt B, Yoon SS. Varying lymphadenectomies for gastric adenocarcinoma in the East compared with the west: effect on outcomes. Am Soc Clin Oncol Educ Book 2012;:250-5. [PMID: 24451743 DOI: 10.14694/EdBook_AM.2012.32.28] [Reference Citation Analysis]
12 Li ZY, Shan F, Zhang LH, Bu ZD, Wu AW, Wu XJ, Zong XL, Wu Q, Ren H, Ji JF. Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer. World J Surg Oncol. 2011;9:110. [PMID: 21942969 DOI: 10.1186/1477-7819-9-110] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
13 Maduekwe UN, Yoon SS. An evidence-based review of the surgical treatment of gastric adenocarcinoma. J Gastrointest Surg 2011;15:730-41. [PMID: 21399886 DOI: 10.1007/s11605-011-1477-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
14 Yoon SS, Yang HK. Lymphadenectomy for gastric adenocarcinoma: should west meet east? Oncologist 2009;14:871-82. [PMID: 19738001 DOI: 10.1634/theoncologist.2009-0070] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 2.8] [Reference Citation Analysis]
15 Persiani R, Rausei S, Pozzo C, Biondi A, Barone C, Cananzi FC, Schinzari G, D’Ugo D. 7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study. Ann Surg Oncol. 2008;15:2146-2152. [PMID: 18543037 DOI: 10.1245/s10434-008-9982-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
16 Farhat FS. A general review of the role of irinotecan (CPT11) in the treatment of gastric cancer. Med Oncol 2007;24:137-46. [PMID: 17848736 DOI: 10.1007/BF02698032] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
17 Wu AW, Xu GW, Wang HY, Ji JF, Tang JL. WITHDRAWN: Neoadjuvant chemotherapy versus none for resectable gastric cancer. Cochrane Database Syst Rev 2007;:CD005047. [PMID: 17943834 DOI: 10.1002/14651858.CD005047.pub3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
18 Wu AW, Xu GW, Wang HY, Ji JF, Tang JL. Neoadjuvant chemotherapy versus none for resectable gastric cancer. Cochrane Database Syst Rev. 2007;CD005047. [PMID: 17443566 DOI: 10.1002/14651858.cd005047.pub2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
19 Brigand C, Arvieux C, Gilly FN, Glehen O. Treatment of peritoneal carcinomatosis in gastric cancers. Dig Dis. 2004;22:366-373. [PMID: 15812161 DOI: 10.1159/000083600] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
20 Silberman H. Perioperative adjunctive treatment in the management of operable gastric cancer. J Surg Oncol 2005;90:174-86; discussion 186-7. [PMID: 15895444 DOI: 10.1002/jso.20226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
21 Zheng LD, Tong QS, Wang L, Liu J, Qian W. Stable transfection of extrinsic Smac gene enhances apoptosis-inducing effects of chemotherapeutic drugs on gastric cancer cells. World J Gastroenterol 2005; 11(1): 79-83 [PMID: 15609401 DOI: 10.3748/wjg.v11.i1.79] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]